Bevacizumab Improves Pathological Response of Colorectal Cancer Liver Metastases Treated with XELOX/FOLFOX

ISSN： 1068-9265

Source： Annals of Surgical Oncology, Vol.17, Iss.8, 2010-08, pp. : 2059-2065

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pathological complete response of colorectal liver metastases following chemotherapy with S-1 and oxaliplatin (SOX) in combination with bevacizumab: A case report

Oncology Letters, Vol. 2, Iss. 2, 2011-01 ,pp. : 201-205

Spandidos Publications

Access to resources Recommend Favorite

Complete pathological response of colorectal liver metastases after chemotherapy and bevacizumab treatment: a case report

By Vitiello F.

Targeted Oncology, Vol. 3, Iss. 4, 2008-10 ,pp. : 253-258

Springer Publishing Company

Access to resources Recommend Favorite

A Case of Resection of Synchronous Multiple Liver Metastases from Colorectal Cancer after FOLFOX Chemotherapy

By Otsuka Shinya Inagaki Masaru Nishie Manabu Hamano Ryousuke Tokunaga Naoyuki Takahashi Kenji Tsunemitsu Yousuke Miyoshi Kazuya Takahashi Masahiko Oosaki Toshihide Iwagaki Hiromi

Japanese Journal of Cancer and Chemotherapy, Vol. 36, Iss. 3, 2009-03 ,pp. : 501-504

Sunmedia

Access to resources Recommend Favorite

Cyclooxygenase-2 expression in colorectal cancer liver metastases

By Hull Mark Fenwick Stephen Chapple Keith Scott N. Toogood Giles Lodge J.

Clinical and Experimental Metastasis, Vol. 18, Iss. 1, 2000-01 ,pp. : 21-27

Springer Publishing Company

Access to resources Recommend Favorite

Defining resectability of colorectal liver metastases: how and why?

By Voorthuizen Theo van van Gulik Thomas M Punt Cornelis JA

Colorectal Cancer, Vol. 2, Iss. 1, 2013-02 ,pp. : 61-72

Future Medicine

Access to resources Recommend Favorite